Clinical management of canine babesiosis

Journal of Veterinary Emergency and Critical Care

Volumn 20, Issue 1, 2010, Pages 77-89

  Ayoob, Ashley L ^a   Hackner, Susan G ^a   Prittie, Jennifer ^a  

^a ANIMAL MEDICAL CENTER   (United States)

Author keywords

Blood borne parasite; Canine hemoprotozoa; Piroplasm

Indexed keywords

BABESIA;

ANTIPROTOZOAL AGENT;

ANIMAL; ANIMAL DISEASE; BABESIOSIS; DISEASE TRANSMISSION; DOG; DOG DISEASE; HOST PARASITE INTERACTION; PARASITOLOGY; PROGNOSIS; PUBLIC HEALTH; REVIEW; RISK FACTOR; TREATMENT OUTCOME; ZOONOSIS;

ANIMALS; ANTIPROTOZOAL AGENTS; BABESIOSIS; DOG DISEASES; DOGS; HOST-PARASITE INTERACTIONS; PROGNOSIS; PUBLIC HEALTH; RISK FACTORS; TREATMENT OUTCOME; ZOONOSES;

EID: 77953439717     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2009.00489.x     Document Type: Review

References (176)

1. Boozer L, Macintire D. Babesia gibsoni: an emerging pathogen in dogs. Compend Contin Educ Vet 2005, 27((1)):33-42.
2. Boozer L, Macintire D. Canine babesiosis. Vet Clin North Am Small Anim Pract 2003, 33:885-904.
3. Taboada J, Lobetti R. Babesiosis. Infectious Diseases of the Dog and Cat 2006, 722-735. Greene C, In, ed, 3rd edn, St Louis, WB Saunders Co, pp
4. Kraje AC. Canine haemobartonellosis and babesiosis. Compend Contin Educ Vet 2001, 23((4)):310-319.
5. Birkenheuer AJ, Levy MG, Stebbins M. Serosurvey of anti-Babesia antibodies in stray dogs and American Pit Bull Terriers and American Staffordshire Terriers from North Carolina. J Am Anim Hosp Assoc 2003, 39:551-557.
6. Taboada J, Harvey JW, Levy MG. Seroprevalence of babesiosis in Greyhounds in Florida. J Am Vet Med Assoc 1992, 200((1)):47-50.
7. Breitschwerdt EB, Malone JB, MacWilliams P. Babesiosis in the Greyhound. J Am Vet Med Assoc 1983, 182((9)):978-982.
8. Yamane I, Gardner IA, Ryan CP. Serosurvey of Babesia canis, Babesia gibsoni, and Ehrlichia canis in pound dogs in California, USA. Prev Vet Med 1994, 18:293-304.
9. Lobetti RG. Canine Babesiosis. Compend Contin Educ Vet 1998, 20((4)):418-430.
10. Levy MG, Breitschwerdt EB, Moncol DJ. Antibody activity to Babesia canis in dogs in North Carolina. Am J Vet Res 1987, 48((3)):339-341.
11. Birkenheuer AJ, Correa MT, Levy MG. Geographic distribution of babesiosis among dogs in the United States and association with dog bites: 150 cases (2000-2003). J Am Vet Med Assoc 2005, 227((6)):942-947.
12. Macintire DK, Boudreaux MK, West GD. Babesia gibsoni infection among dogs in the southeastern United States. J Am Vet Med Assoc 2002, 220((3)):325-329.
13. Irizarry-Rovria AR, Stephens J, Christian J. Babesia gibsoni infection in a dog from Indiana. Vet Clin Pathol 2001, 30((4)):180-188.
14. Birkenheuer AJ, Levy MG, Savary KCM. Babesia gibsoni infections in dogs from North Carolina. J Am Anim Hosp Assoc 1999, 35:125-128.
15. Anderson JF, Magnarelli LA, Donner CS. Canine Babesia new to North America. Science 1979, 204((4400)):1431-1432.
16. Conrad P, Thomford J, Yamane I. Hemolytic anemia caused by Babesia gibsoni infection in dogs. J Am Vet Med Assoc 1991, 199((5)):601-605.
17. Meinkoth JH, Kocan AA, Loud SD. Clinical and hematologic effects of experimental infection of dogs with recently identified Babesia gibsoni-like isolates from Oklahoma. J Am Vet Med Assoc 2002, 220((2)):185-189.
18. Birkenheuer AJ, Greene C, Silver S. Babesia gibsoni infections in non-American Pit Bull Terriers. In: Proceedings of the American College of Veterinary Internal Medicine, Charlotte, USA, 2003, p. 927
19. Kjemtrup AM, Wainwright K, Miller M. Babesia conradae, sp. nov, a small canine Babesia identified in California. Vet Parasitol 2006, 138((1-2)):103-111.
20. Zahler M, Rinder H, Zweygarth E. Babesia gibsoni of dogs from North America and Asia belong to different species. Parasitology 2000, 120:365-369.
21. Abu M, Hara I, Naito I. Babesia infections in puppies probably due to transplacental transmission. J Vet Med Educ 1973, 609:203-206.
22. M'qhiribi Y, Boutattour A. Detection and molecular characterization of Babesia canis vogeli from naturally infected dogs and Rhipicephalus sanguineus ticks in Tunisia. Vet Parasitol 2008, 152((1-2)):1-7.
23. Higuchi S, Fujimori M, Hoshi F. Development of Babesia gibsoni in the salivary glands of the larval tick, Rhipicephalus sanguineus. J Vet Med Sci 1995, 57:117-119.
24. Higuchi S, Izumitani M, Hoshi H. Development if Babesia gibsoni in the midgut of a larval tick. J Vet Med Sci 1999, 61:689-691.
25. Higuchi S, Kuroda H, Hoshi H. Development of Babesia gibsoni in the midgut of the nymphal stage of the tick. J Vet Med Sci 1999, 61:697-699.
26. Yamane J, Garner IA, Telford SR. Vector competence of Rhipicephalus sanguineus and Dermacentor variabilis for American isolates of Babesia gibsoni. Exp Appl Acarol 1993, 17:913-919.
27. Friedhoff KT. Transmission of Babesia. Babesiosis of Domestic Animals and Man 1988, 23-52. Ristic M. ed, Boca Raton, CRC Press, pp
28. Igarashi I, Aikawa M, Kreier JP. Host cell-parasite interaction in babesiosis. Babesiosis of Domestic Animals and Man 1988, 53-69. Ristic M, In, ed, Boca Raton, CRC Press, pp
29. Martinod S, Brossard M, Moreau Y. Immunity of dogs against Babesia canis, its vector tick Dermacentor reticulates, and Ixodes ricinus in endemic area. J Parasitol 1985, 71:269-273.
30. Correa WM. Canine babesiosis: transplacental transmission. Bibliobico 1974, 40:321-322.
31. Fukumoto S, Suzuki H, Igarashi I. Fatal experimental transplacental Babesia gibsoni infections in dogs. Int J Parasitol 2005, 35((9)):1031-1035.
32. Jefferies R, Ryan UM, Jardine J. Blood, bull terriers and babesiosis: further evidence for direct transmission of Babesia gibsoni in dogs. Aust Vet J 2007, 85((11)):459-463.
33. Stegeman JR, Birkenheuer AJ, Kruger JM. Transfusion-associated Babesia gibsoni infection in a dog. J Am Vet Med Assoc 2003, 222((7)):959-963.
34. Freeman MJ, Kirby BM, Panciera DL. Hypotensive shock syndrome associated with acute Babesia canis infection in a dog. J Am Vet Med Assoc 1994, 204((1)):94-96.
35. Groves MG, Yap LF. Babesia gibsoni in a dog. J Am Vet Med Assoc 1968, 153:689-694.
36. Taboada J, Merchant SR. Babesiosis of companion animals and man. Vet Clin North Am Small Anim Pract 1991, 21((1)):103-123.
37. Wright IG, Goodger BV. Pathogenesis of babesiosis. Babesiosis of Domestic Animals and Man 1988, 99-118. Ristic M, In, ed, Boca Raton, CRC Press, pp
38. Schetters TH, Kleuskens J, Scholtes N. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens. Parasite Immunol 1995, 17:215-218.
39. Uilenberg G, Franssen FFJ, Perie NM. Three groups of Babesia canis distinguished and a proposal for nomenclature. Vet Q 1989, 11:33-40.
40. Bobade PA, Oduye OO, Aghomo HO. Prevalence of antibodies against Babesia canis in dogs in an endemic area. Rev Elev Med Vet Pays Trop 1989, 42:211-217.
41. Jacobson LS, Clark IA. The pathophysiology of canine babesiosis: new aroaches to an old puzzle. J South Afr Vet Assoc 1994, 65:134-145.
42. Camacho A, Pallas E, Gestal J. Babesia canis infection in a splenectomized dog. Bull Soc Pathol Exot 2002, 95((1)):17-19.
43. Kawamura M, Maede Y, Namioka S. Mitogenic responsibilities of lymphocytes in canine babesiosis and the effects of splenectomy on it. Jpn J Vet Res 1987, 35((1)):1-10.
44. Wozniak E, Barr B, Thomford J. Clinical, anatomic, and immunopathologic characterization of Babesia gibsoni infection in the domestic dog (Canis faniliaris). J Parasitol 1997, 83((4)):692-699.
45. Mathe A, Voros K, Nemeth T. Clinicopathological changes and effect of imidocarb therapy in dogs experimentally infected with Babesia canis. Acta Vet Hung 2006, 54((1)):19-33.
46. Camacho A, Pallas E, Gestal J. Natural infection by a Babesia microti-like piroplasm in a splenectomized dog. Vet Rec 2002, 150((12)):381-382.
47. Meinkoth J, Kocan A, Loud S. Clinical and hematologic effects of experimental infection of dogs with recently identified Babesia-gibsoni-like isolates from Oklahoma. J Am Vet Med Assoc 2002, 220((2)):185-189.
48. Wright I. The isolation of Haemobartonella canis in association with Nanesia canis in a splenectomised dog. Aust Vet J 1971, 47((4)):157-159.
49. Makinde MO, Bobade PA. Osmotic fragility of erythrocytes in clinically normal dogs and dogs with parasites. Res Vet Sci 1994, 57:343-348.
50. Adachi K, Tateishi M, Horii Y. Reactivity of serum anti-erythrocyte membrane antibody in Babesia gibsoni-infected dogs. J Vet Med Sci 1994, 56:997-999.
51. Adachi K, Tateishi M, Horii Y. Immunologic characteristics of anti-erythrocyte membrane antibody produced in dogs during Babesia gibsoni infection. J Vet Med Sci 1995, 57:121-123.
52. Adachi K, Yoshimoto A, Hasegawa T. Anti-erythrocyte membrane antibodies detected in sera of dogs naturally infected with Babesia gibsoni. J Vet Med Sci 1992, 54:1081-1084.
53. Morita T, Saeki H, Imai S. Reactivity of anti-erythrocyte antibody induced by Babesia gibsoni infection against aged erythrocytes. Vet Parasitol 1995, 58:291-299.
54. Murase T, Naede Y. Increased erythrophagocytic activity of macrophages in dogs with Babesia gibsoni infection. Nippon Juigaku Zasshi 1990, 52:321-327.
55. Ohnishi T, Ueda K, Horie M. Serum hemolytic activity in dogs with Babesia gibsoni. J Parasitol 1990, 76:564-567.
56. Murase T, Ueda T, Yamato O. Oxidative damage and enhanced erythrophagocytosis in canine erythrocytes infected with Babesia gibsoni. J Vet Med Sci 1996, 58:259-261.
57. Hosaain MA, Yamato O, Yamasaki M. Serum from dogs infected with Babesia gibsoni inhibits maturation of reticulocytes and erythrocyte 5′nucleotidase activity in vitro. J Vet Med Sci 2003, 65:1281-1286.
58. Hossain MA, Yamato O, Yamasaki M. Inhibitory effect of pyrimidine and purine nucleotides on the multiplication of Babesia gibsoni: possible cause of low parasitemia and simultaneous reticulocytosis in canine babesiosis. J Vet Med Sci 2004, 66:389-399.
59. Hossain MA, Yamato O, Kim G. Suppressive effect of culture supernatant of erythrocytes and serum from dogs infected with Babesia gibsoni on the morphologic maturation of canine reticulocytes in vitro. J Vet Med Sci 2007, 8((2)):169-174.
60. Adachi K, Tateishi M, Horli Y. Elevated erythrocyte-bound IgG value in dogs with clinical Babesia gibsoni infection. J Vet Med Sci 1994, 56((4)):757-759.
61. Adachi K, Makimura S. Changes in anti-erythrocyte membrane antibody level of dogs experimentally infected with Babesia gibsoni. J Vet Med Sci 1992, 54((6)):1221-1223.
62. Farwell G, LeGrand E, Cobb C. Clinical observations on Babesia gibsoni and Babesia canis infections in dogs. J Am Vet Med Assoc 1982, 180((5)):507-511.
63. Morita T, Saeki H, Ishii T. Erythrocyte oxidation in artificial Babesia gibsoni infection. Vet Parasitol 1996, 63((1-2)):1-7.
64. Lobetti RG, Reyers F. Methaemoglobinuria in naturally occurring Babesia canis infection. J South Afr Vet Assoc 1996, 67:88-90.
65. Otsuka Y, Yamasaki M, Yamato O. The effect of macrophages on the erythrocyte oxidative damage and the pathogenesis of anemia in Babesia gibsoni-infected dogs with low parasitemia. J Vet Med Sci 2002, 64((3)):221-226.
66. Otsuka Y, Yamasaki M, Yamato O. Increased generation of superoxide in erythrocytes infected with Babesia gibsoni. J Vet Med Sci 2001, 63:1077-1081.
67. Morita T, Saeki H, Imai S. Reactivity of anti-erythrocyte antibody induced by Babesia gibsoni infection against aged erythrocytes. Vet Parasitol 1995, 58((4)):291-299.
68. Jacobson LS, Lobetti RG. Rhabdomyolysis as a complication of canine babesiosis. J Small Anim Pract 1996, 37:286-297.
69. Lobetti RG, Reyers F, Nesbit JW. The comparative role of hemoglobinemia and hypoxia in the development of canine babesial nephropathy. J South Afr Vet Assoc 1996, 67:188-198.
70. Jacobson LS. Cerebellar ataxia as a possible complication of babesiosis in two dogs. J South Afr Vet Assoc 1994, 65:130-131.
71. Welzl C, Leisewitz AL, Jacobson LS. Systemic inflammatory response syndrome and multiple-organ damage/dysfunction in complicated canine babesiosis. J South Afr Vet Assoc 2001, 72:158-162.
72. Leisewitz AL, Jacobson LS, de Morais HSA. The mixed acid-base disturbances of severe canine babesiosis. J Vet Intern Med 2001, 15:445-452.
73. Jacobson L. The South African form of severe and complicated canine babesiosis: clinical advances 1994-2004. Vet Parasitol 2006, 138((1-2)):126-139.
74. Mahr A, Lobetti R, Van der Lugt J. Acute pancreatitis: a newly recognized potential complication of canine babesiosis. J South Afr Vet Assoc 2000, 71((4)):232-239.
75. Keller N, Jacobson LS, Nel M. Prevalence and risk factors of hypoglycemia in virulent canine babesiosis. J Vet Intern Med 2004, 18:265-270.
76. Mathe A, Voros K, Papp L. Clinical manifestations of canine babesiosis in Hungary (63 cases). Acta Vet Hung 2006, 54((3)):367-385.
77. Tuttke A, Birkenheuer A, Juopperi T. Concurrent bartonellosis and babesiosis in a dog with persistent thrombocytopenia. J Am Vet Med Assoc 2003, 223((9)):1306-1310.
78. Ruiz de Gopegui R, Penalba B, Giocoa A. Clinico-pathological findings and coagulation disorders in 45 cases of canine babesiosis in Spain. Vet J 2007, 174((1)):129-132.
79. Furlanello T, Caldin M, Patron C. Review of coagulation disorders in naturally occurring cases of canine babesiosis induced by In: Proceedings of the 13th ECVIM Meeting, Upsaala, Sweden, 2003, p. 476
80. Ulutas B, Bayramli G, Ulatas P. Serum concentration of some acute phase proteins in naturally occurring canine babesiosis: a preliminary study. Vet Clin Pathol 2005, 34((2)):144-147.
81. Schetters T, Kleuskens J, Scholtes N. Vaccination of dogs against Babesia canis infection. Vet Parasitol 1997, 73((1-2)):35-41.
82. Camacho A, Guitan E, Pallas E. Azotemia and mortality among Babesia microti-like infected dogs. J Vet Intern Med 2004, 18((2)):141-146.
83. Maitha A, Dobos-Kovaics M, Varas K. Histological and ultrastructural studies of renal lesions in Babesia canis infected dogs treated with imidocarb. Acta Vet Hung 2007, 55((4)):511-523.
84. Wozniak EJ, Barr BC, Thomford JW. Clinical, anatomic, and immunopathologic characterization of Babesia gibsoni infection in the domestic dog (Canis familiaris). J Parasitol 1997, 83:692-699.
85. Scally M, Leisewitz A, Lobetti R. The elevated serum urea: creatinine ratio in canine babesiosis in South Africa is not of renal origin. J South Afr Vet Assoc 2006, 77((4)):175-178.
86. Lobetti R, Jacobson L. Renal involvement in dogs with babesiosis. J South Afr Vet Assoc 2001, 72((1)):23-28.
87. Bonfanti U, Zini E, Minetti E. Free light-chain proteinuria and normal renal histopathology and function in 11 dogs exposed to Leishmania infantum, Ehrlichia canis, and Babesia canis. J Vet Intern Med 2004, 18((5)):618-624.
88. Okoh A. A case of cerebral babesiosis in the dog. Bull Anim Health Prod Afr 1978, 26((2)):118-119.
89. Jacobson L, Lobetti R, Vaughan-Scott T. Blood pressure changes in dogs with babesiosis. J South Afr Vet Assoc 2000, 71((1)):14-20.
90. Lobetti R. Cardiac involvement in canine babesiosis. J South Afr Vet Assoc 2005, 76((1)):4-8.
91. Lobetti R, Dvir E, Pearson J. Cardiac troponins in canine babesiosis. J Vet Intern Med 2002, 16((1)):63-68.
92. Rees P, Schoeman J. Plasma insulin concentrations in hypoglycemic dogs with Babesia canis rossi infection. Vet Parasitol 2008, 152((1-2)):60-66.
93. Jacobson L, Lobetti R. Glucose, lactate, and pyruvate concentrations in dogs with babesiosis. Am J Vet Res 2005, 66((2)):244-250.
94. Nel M, Lobetti R, Keller N. Prognostic value of blood lactate, blood glucose, and hematocrit in canine babesiosis. J Vet Intern Med 2004, 18:471-476.
95. Abdullahi SU, Mohammed AA, Trimnell AR. Clinical and haematological findings in 70 naturally occurring cases of canine babesiosis. J Small Anim Pract 1990, 31:145-147.
96. Irwin PJ, Hutchinson GW. Clinical and pathological findings of Babesia infection in dogs. Aust Vet J 1991, 68:204-209.
97. Masuda T, Baba E, Arakawa A. Relapse of canine babesiosis after prednisolone treatment. Mod Vet Pract 1983, 64:931-932.
98. Schetters TP, Moubri K, Precigout E. Different Babesia canis isolates, different diseases. Parasitology 1997, 115:485-493.
99. Casapulla R, Baldi L, Avallone V. Canine piroplasmosis due to Babesia gibsoni: clinical and morphological aspects. Vet Rec 1998, 142:168-169.
100. Kettner F, Reyers F, Miller D. Thrombocytopenia in canine babesiosis and its clinical usefulness. J South Afr Vet Assoc 2003, 74:63-68.
101. Bahm H, Leisewitz A, Thompson P. Capillary and venous Babesia canis rossi parasitemias and their association with outcome of infection and circulatory compromise. Vet Parasitol 2006, 141((1-2)):18-29.
102. Yamasaki M, Asano H, Otsuka Y. Use of canine red blood cell with high concentrations of potassium, reduced glutathione, and free amino acid as host for in vitro cultivation of Babesia gibsoni. Am J Vet Res 2000, 61:1520-1524.
103. Yamasaki M, Otsuka Y, Yamato O. The cause of the predilection of Babesia gibsoni for reticulocytes. J Vet Med Sci 2000, 62:737-741.
104. Mattia AR, Waldron MA, Sierra LS. Use of the quantitative buffy coat system for detection of parasitemia in patients with babesiosis. J Clin Microbiol 1993, 31:2816-2818.
105. Adachi K, Wantanabe T, Yamane S. Isolation of Babesia gibsoni piroplasms from infected erythrocytes of dogs. J Vet Med Sci 1993, 55((3)):487-490.
106. Comazzi S, Paltrinieri S, Manfredi M. Diagnosis of canine babesiosis by Percoll gradient separation of parasitized erythrocytes. J Vet Diagn Invest 1999, 11((1)):102-104.
107. Yamasaki M, Hwang S, Ohta H. Flow cytometry to evaluate the level of Babesia gibsoni parasitemia in vivo and in vitro by using the fluorescent nucleic acid stain SYTO16. Jpn J Vet Res 2008, 55((4)):129-136.
108. Radi ZA, Styer EL, Frazier KS. Electron microscopic study of canine Babesia gibsoni infection. J Vet Diagn Invest 2004, 16:229-233.
109. Fukata T, Ohnishi T, Okuda S. Detection of canine erythrocyte infected with Babesia gibsoni by flow cytometry. J Parasitol 1996, 82:641-642.
110. Uemura T, Suzuki S, Ohnishi T. Flow cytometric enumeration of reticulocyte in the peripheral blood from canine infected with Babesia gibsoni. Zentralbl Veterinarmed 1990, 37:468-472.
111. Bicalho KA, Ribeiro MF, Martino-Filho OA. Molecular fluorescent approach to assessing hemoprotozoan Babesia infections in dogs. Vet Parasitol 2004, 125:221-255.
112. Quick RE, Herwaldt BL, Thomford JW. Babesiosis in Washington State: a new species of Babesia? Ann Intern Med 1993, 119:284-290.
113. Weiland G, Reiter I. Methods for the measurement of the serological response to Babesia. Babesiosis of Domestic Animals and Man 1988, 143-162. Ristic M, In, ed, Boca Raton, FL, CRC Press, pp
114. Vercammen F, Deken R, Maes L. Clinical and serological observations on experimental infections with Babesia canis and its diagnosis using the IFAT. Parasite 1995, 2((4)):401-410.
115. Yamane I, Thomford JW, Gardner IA. Evaluation of the indirect fluorescent antibody test for diagnosis of Babesia gibsoni infections in dogs. Am J Vet Res 1993, 54:1579-1584.
116. Martinod S, Laurent N, Mareau Y. Resistance and immunity of dogs against Babesia canis in an endemic area. Vet Parasitol 1986, 19((3-4)):245-254.
117. Wanduragala L, Kakoma I, Clabaugh G. Development of Dot-enzyme immunoassay for diagnosis of canine babesiosis. Am J Trop Med Hyg 1987, 36((1)):20-21.
118. Verdida RA, Hara OA, Xuan X. Serodiagnosis of Babesia gibsoni infection in dogs by an imporved enzyme-linked immunosorbent assay with recombinant truncated P50. J Vet Med Sci 2004, 66:1517-1521.
119. Birkenheuer AJ, Levy MG, Breitschwerdt EB. Development and evaluation of a seminested PCR for detection and differentiation of Babesia gibsoni (Asian genotype) and B. canis DNA in canine blood samples. J Clin Microbiol 2003, 1:4172-4177.
120. Miyama T, Inokuma H, Itamoto K. Clinical usefulness of antibodies against Babesia gibsoni detected by ELISA with recombinant P50. J Vet Med Sci 2006, 68((12)):1371-1373.
121. Fukumoto S, Xuan X, Nishikawa Y. Identification and expression of a 50-kilodalton surface antigen of Babesia gibsoni and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay. J Clin Microbiol 2001, 39((7)):2603-2609.
122. Fukumoto S, Xuan X, Inoue N. Molecular characterization of a gene encoding a 29-kDa cytoplasmic protein of Babesia gibsoni and evaluation of its diagnostic potential. Mol Biochem Parasitol 2003, 131((2)):129-136.
123. Jia H, Zhou J, Ikadai I. Identification of a novel gene encoding a secreted antigen 1 of Babesia gibsoni and evaluation of its use in serodiagnosis. Am J Trop Med Hyg 2006, 75((5)):843-850.
124. Aboge G, Jia H, Zhou J. Molecular characterization of a novel 32-kDa merezoite antigen of Babesia gibsoni with a better diagnostic performance by enzyme-linked immunosorbent assay. Parasitology 2007, 134((9)):1185-1194.
125. Goo Y, Jia H, Oluga G. Babesia gibsoni: serodiagnosis of infection in dogs by an enzyme-linked immunosorbent assay with recombinant BgTRAP. Exp Parasitol 2008, 118((4)):555-560.
126. Fukumoto S, Xuan X, Shigeno S. Development of a polymerase chain reaction method for diagnosing Babesia gibsoni infection in dogs. J Vet Med Sci 2001, 63:977-981.
127. Martin A, Dunstan R, Roberts T. Babesia canis vogeli: a novel PCR for its detection in dogs in Australia. Exp Parasitol 2006, 112((1)):63-65.
128. Jefferies R, Ryan U, Irwin P. PCR-RFLP for the detection and differentiation of the canine piroplasm species and its use with filter paper-based technologies. Vet Parasitol 2007, 144((1-2)):20-27.
129. Ano H, Makimura S, Harasawa R. Detection of Babesia species from infected dog blood by polymerase chain reaction. J Vet Med Sci 2001, 63:111-113.
130. Inokuma H, Okuda M, Yoshizaki Y. Clinical observations of Babesia gibsoni infection with low parasitemia confirmed by PCR in dogs. Vet Rec 2005, 156:116-118.
131. Duarte S, Linhares G, Romanowsky T. Assessment of primers designed for the subspecies-specific discrimination among Babesia canis canis, Babesia canis vogeli, and Babesia canis rossi by PCR assay. Vet Parasitol 2008, 152((1-2)):16-20.
132. Birkenheuer AJ, Neel J, Ruslander D. Detection and molecular characterization of a novel large Babesia species in a dog. Vet Parasitol 2004, 124:151-160.
133. Kuttler KL. Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis. J Am Vet Med Assoc 1980, 176:1103-1108.
134. Penzhorn BL, Lewis BD, de Waal DT. Sterilisation of Babesia canis infections by imidocarb alone or in combination with diminazene. J South Afr Vet Assoc 1995, 66:157-159.
135. Jacobson L, Reyers F, Berry W. Changes in haematocrit after treatment of uncomplicated babesiosis: a comparison between diminazene and trypan blue, and an evaluation of the influence of parasitemia. J South Afr Vet Assoc 1996, 67((2)):77-82.
136. Stewart C. A comparison of the efficacy of isometamindium, amilcarbalide, and diminazene against Babesia canis in dogs and the effect on subsequent immunity. J South Afr Vet Assoc 1983, 54((1)):47-51.
137. Kuttler KL. Chemotherapy of babesiosis. Babesiosis of Domestic Animals and Man 1988, 227-242. Ristic M. In, ed, Boca Raton, FL, CRC Press, pp
138. Adeyanju BJ, Aliu YO. Chemotherapy of canine ehrlichiosis and babesiosis with imidocarb dipropionate. J Am Anim Hosp Assoc 1982, 18:827-830.
139. Uilenberg G, Verdiesen P, Zwart D. Imidocarb: a chemoprophylactic experiment with Babesia canis. Vet Q 1981, 3((3)):118-123.
140. Vercammen F, DeDeken R, Maes L. Duration of protective immunity in experimental canine babesiosis after homologous and heterologous challenge. Vet Parasitol 1997, 68:51-55.
141. Abdullah AS, Sheikh-Omar AR, Baggot AR. Adverse effects of imidocarb dipropionate (Imizol7) in a dog. Vet Res Commun 1984, 8:55-59.
142. Kock N, Kelly P. Massive hepatic necrosis associated with accidental imidocarb dipropionate toxicosis in a dog. J Comp Pathol 1991, 104:113-116.
143. Jefferies R, Ryan U, Jardine J. Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy. Exp Parasitol 2007, 117((2)):115-123.
144. Birkenheuer A, Levy M, Breitschwerdt E. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. J Vet Intern Med 2004, 18((4)):494-498.
145. Hughes WT, Helieh SO. Successful prevention and treatment of babesiosis with atovaquone. J Infect Dis 1995, 172:1042-1046.
146. Weiss LM, Wittner M, Wasserman S. Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J Infect Dis 1993, 168:1289-1292.
147. Matsuu A, Koshida Y, Kawahara M. Efficacy of atovaquone in vivo and in vitro. Vet Parasitol 2004, 124:9-18.
148. Wulansari R, Wijaya A, Ano H. Lymphocyte subsets and specific IgG antibody levels in clindamycin-treated and untreated dogs experimentally infected with Babesia gibsoni. J Vet Med Sci 2003, 65:579-584.
149. Wulansari R, Wijaya A, Ano H. Clindamycin in the treatment of Babesia gibsoni infection in dogs. J Am Anim Hosp Assoc 2003, 39((6)):558-562.
150. Vercammen F, Deken R, Maes L. Prophylactic treatment of experimental canine babesiosis (Babesia canis) with doxycycline. Vet Parasitol 1996, 66((3-4)):251-255.
151. Suzuki K, Wakabayashi H, Takahashi M. A possible treatment strategy and clinical factors to estimate the treatment response in Babesia gibsoni infection. J Vet Med Sci 2007, 69((5)):563-568.
152. Chaudhuri S, Varshney J. Clinical management of babesiosis in dogs with homeopathic Crotalus horridus 200C. Homeopathy 2007, 96((2)):90-94.
153. Jacobson L, Swan G. Supportive treatment of canine babesiosis. J South Afr Vet Assoc 1995, 66((2)):95-105.
154. Dryden M, Payne P. Biology and control of ticks infesting dogs and cats in North America. Vet Ther 2004, 5((2)):139-54.
155. Dryden M, Payne P, Hostetler J. Evaluation of an imidacloprid (8.8% w/w)-permethrin (44% w/w) topical spot on and a fiprinil (9.8% w/w) -(S)-methoprene (8.8% w/w) topical spot on to repel, prevent attachment, and kill adult Rhipicephalus sanguineus and Dermacentor variabilis ticks on dogs. Vet Ther 2006, 7((3)):187-198.
156. Estrada-Pena A, Ascher F. Comparison of an amitraz-impregnated collar with topical administration of fipronil for prevention of experimental and natural infestations by the brown dog tick (Rhipicephalus sanguineus). J Am Vet Med Assoc 1999, 214:1799-1803.
157. Hunter JS. Efficacy of frontline spray and frontline topspot. Compend Contin Educ Vet 1997, 19((suppl)):15-16.
158. Cruthers L, Slone R, Arther RG. K9 Advantix (imidacloprid plus permethrin) for controlling ticks and mosquitoes on dogs. Compend Contin Educ Vet 2003, 25((suppl 5A)):15-18.
159. Epe C, Coati N, Stanneck D. Efficacy of the compound preparation imidacloprid 10%/permethrin 50% spot-on against ticks (I. ricinus, R. sanguineus) and fleas (Ct. felis) on dogs. Parasitol Res 2003, 90((suppl 3)):S122-S124.
160. Elfassy OJ, Goodman FW, Levy SA. Efficacy of an amitraz-impregnated collar in preventing transmission of Borrelia burgdorferi by adult Ixodes scapularis to dogs. J Am Vet Med Assoc 2001, 219:185-189.
161. Last R, Hill J, Matjila P. A field trial evaluation of the prophylactic efficacy of amitraz-impregnated collars against canine babesiosis (Babesia canis rossi) in South Africa. J South Afr Vet Assoc 2007, 78((2)):63-65.
162. Meeusen E, Walker J, Peters A. Current status of veterinary vaccines. Clin. Microbiol Rev 2007, 20((3)):489-510.
163. Schetters T. Vaccination against canine babesiosis. Trends Parasitol 2006, 21((4)):179-184.
164. Moreau Y, Vidor E, Bissuel G. Vaccination against canine babesiosis: an overview of field observations. Trans R Soc Trop Med Hyg 1989, 83((suppl)):95-96.
165. Schetters TP, Kleuskens J, Carcy B. Vaccination against large Babesia species from dogs. Parassitologia 2007, 49((1)):13-17.
166. Schetters TP, Kleuskens J, Scholtes NC. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants. Vet Parasitol 2006, 138((1-2)):140-146.
167. Schetters TP, Strydom T, Crafford D. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants. Vet Parasitol 2007, 144((1-2)):10-19.
168. Schetters TP, Kleuskens JA, Scholtes. Vaccination of dogs against heterologous Babesia canis infections using antigens from culture supernatants. Vet Parasitol 2001, 100((1-2)):75-86.
169. Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol 2000, 30:1323-1377.
170. Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis 1996, 22:809-812.
171. Persing DH, Herwaldt BL, Glaser C. Infection with a Babesia-like organism in northern California. N Engl J Med 1995, 332:298-303.
172. Hatcher JC, Greenberg PD, Antique J. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001, 32:1117-1125.
173. Herwaldt BL, Persing DH, Precigout EA. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 1996, 124:643-650.
174. Herwaldt BL, Springs FE, Roberts PP. Babesiosis in Wisconsin: a potentially fatal disease. Am J Trop Med Hyg 1995, 53:146-151.
175. Schuster F. Cultivation of Babesia and Babesia-like blood parasites: agents of an emerging zoonotic disease. Clin Microbiol Rev 2002, 15((3)):365-373.
176. Matsuu A, Koshida Y, Kawahara M. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro. Vet Parasitol 2004, 124((1-2)):9-18.